Form 8-K - Current report:
SEC Accession No. 0001437749-23-035170
Filing Date
2023-12-22
Accepted
2023-12-22 09:08:35
Documents
13
Period of Report
2023-12-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K plse20231219_8k.htm   iXBRL 8-K 39225
  Complete submission text file 0001437749-23-035170.txt   172173

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA plse-20231219.xsd EX-101.SCH 3410
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE plse-20231219_def.xml EX-101.DEF 11425
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20231219_lab.xml EX-101.LAB 15311
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20231219_pre.xml EX-101.PRE 11585
7 EXTRACTED XBRL INSTANCE DOCUMENT plse20231219_8k_htm.xml XML 2555
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 231507419
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)